BioArctic AB (OSTO:BIOA B) Price-to-Operating-Cash-Flow : 58.33 (As of May. 11, 2024)

View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Price-to-Operating-Cash-Flow?

As of today (2024-05-11), BioArctic AB's share price is kr203.00. BioArctic AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr3.48. Hence, BioArctic AB's Price-to-Operating-Cash-Flow Ratio for today is 58.33.

The historical rank and industry rank for BioArctic AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:BIOA B' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.87 Med: 57.92 Max: 200
Current: 56.09

During the past 9 years, BioArctic AB's highest Price-to-Operating-Cash-Flow Ratio was 200.00. The lowest was 13.87. And the median was 57.92.

OSTO:BIOA B's Price-to-Operating-Cash-Flow is ranked worse than
77.1% of 297 companies
in the Biotechnology industry
Industry Median: 26.92 vs OSTO:BIOA B: 56.09

BioArctic AB's Cash Flow from Operations per share for the three months ended in Dec. 2023 was kr1.44. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr3.48.

During the past 9 years, BioArctic AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 12.00% per year. The lowest was -129.90% per year. And the median was -5.10% per year.

BioArctic AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BioArctic AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Price-to-Operating-Cash-Flow Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

25.55

76.51

BioArctic AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	72.62	86.61	202.14	76.51

Competitive Comparison of BioArctic AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, BioArctic AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioArctic AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Price-to-Operating-Cash-Flow falls into.

BioArctic AB Price-to-Operating-Cash-Flow Calculation

BioArctic AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	203.00	/	3.48
	=	58.33

BioArctic AB's Share Price of today is kr203.00.
BioArctic AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3.48.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BioArctic AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB (OSTO:BIOA B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BRCTF:USA 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (OSTO:BIOA B) Headlines

No Headlines